You are using an out of date browser that our site does not support. Please, update your browser for a faster browsing experience, better security, and to experience the web's latest features. Click here to update or install a different browser.
Methodist Healthcare celebrates its Centennial this year. As the health system celebrates a century of innovation, it also looks forward to a dedication of the future of medicine. Evan Glazer, MD, a surgical oncologist with UT Methodist Physicians and West Cancer Center and assistant professor in the Division of Surgical Oncology in the University of Tennessee Health Science Center Department of Surgery, personifies that dedication. He is passionate about providing his patients with the most advanced cancer care and most effective treatment options.
Earlier this year, he spent 18 days in South Korea learning, sharing, and observing the most common types of cancers South Korean doctors see, the stages at which cancer patients seek care, and the treatments South Korean physicians offer patients.
“Even after surgeons have completed formal training, we never stop learning,” said Dr. Glazer. “The experience I had to learn from other physicians on an international platform at the Korean Society of Surgical Oncology (KSSO) – the Seoul International Symposium of Surgical Oncology was extraordinary. To have this opportunity on an international level offered great insight into different approaches to complex surgical problems surgical oncologists routinely encounter.”
Through a competitive application process, he was selected by the Society of Surgical Oncology (SSO) to be the one physician to visit South Korea and observe at Seoul National University Hospital (SNUH) and the Korean National Cancer Center (NCC).
Dr. Glazer noticed that the patients he sees in the Mid-South with gastric cancers seek medical attention when their cancers are much more advanced than they are in South Korea. The explanation he says is due to the screening programs that are offered in South Korea. In the United States, we have robust screenings in place for colon and breast cancer, but not for gastric cancers that are not as common in the U.S., but are very common in South Korea.
He said his experience in South Korea reinforced the value of multidisciplinary care. “Seeing how their surgical oncologists, gastroenterologists, medical oncologists, radiologists, and radiation oncologists all worked together to support the surgical oncologist validated the importance of teamwork.”
Surgeons in South Korea couldn’t do their jobs without other physicians identifying liver cancer earlier.
Dr. Glazer has seen firsthand, that patients who seek cancer care at Methodist and West Cancer Center receive the level of care that meets national and international standards. He is extremely proud of the dedicated teamwork at both medical institutions and he’s already working on new trials to help save more lives especially in his area of focus - pancreatic and liver cancers.
For more information about cancer care, visit methodisthealth.org.